BIRAs will bring together representatives from academia, the pharma industry and clinicians, working in the immune metabolism field, to discuss the mechanisms of disregulated immune function in disease and the challenges facing the development of new immune modulatory treatments. Focusing on the cellular mechanisms to translate key research from ‘bench to bedside’. Delegates will have great opportunities for networking and building collaborations.